Kuypers KP

Department of Neuropsychology and Psychopharmacology, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, the Netherlands.

4 preprints · 6 papers · ORCID

PreprintPsychedelics

Memory experiences under psychedelics – an exploratory prospective online study

Kangaslampi S, Kuypers KP

Europe PMC2026
PreprintPsychedelics

Actions speak louder than words: Towards measuring real-world behaviour change in psychedelic research

Roche S, Kuypers KP, Wensing J +1

Europe PMC2026
PreprintPsilocybin

Sex Differences in Acute Responses to Psychedelics: Evidence for Greater Subjective Intensity and Impairment in Female Participants

Mason NL, Haijen-Bongers EC, Kuypers KP +4

Europe PMC2026
ArticlePsilocybin

Knowledge gaps in psychedelic medicalisation: Clinical studies and regulatory aspects.

E-Wen McCulloch D, Liechti ME, Kuypers KP +9

Europe PMC2024
ArticlePsilocybin

Investigation of self-treatment with lysergic acid diethylamide and psilocybin mushrooms: Findings from the Global Drug Survey 2020.

Kopra EI, Ferris JA, Winstock AR +3

Europe PMC2023
PreprintPsilocybin

Assessment of the acute effects of 2C-B vs psilocybin on subjective experience, mood and cognition

Mallaroni P, Mason NL, Reckweg JT +6

Europe PMC2023
ArticlePsychedelics

Analgesic potential of macrodoses and microdoses of classical psychedelics in chronic pain sufferers: a population survey.

Bonnelle V, Smith WJ, Mason NL +5

Europe PMC2022
ArticleLSD

A low dose of lysergic acid diethylamide decreases pain perception in healthy volunteers.

Ramaekers JG, Hutten N, Mason NL +6

Europe PMC2021
ArticlePsilocybin

Microdosing psychedelics: More questions than answers? An overview and suggestions for future research.

Kuypers KP, Ng L, Erritzoe D +6

Europe PMC2019
ArticleAyahuasca

Ayahuasca enhances creative divergent thinking while decreasing conventional convergent thinking.

Kuypers KP, Riba J, de la Fuente Revenga M +3

Europe PMC2016